Brief: Orocidin develops novel cGMP manufacturing process in collaboration with Syngene
20/10/2025 14:18
Oct 20 (Reuters) - Nordicus Partners Corp NORD.PK: OROCIDIN DEVELOPS NOVEL CGMP MANUFACTURING PROCESS IN COLLABORATION WITH SYNGENE Source text: ID:nGNXbmPcss Further company coverage: NORD.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nordicus Partners
See all newsNASDAQ RESUMED AT 09:48 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:43 AM
Brief: Nordicus Partners Corporation Announces Uplisting To The Nasdaq Capital Market
Brief: Orocidin develops novel cGMP manufacturing process in collaboration with Syngene
Brief: Nordicus Partners Applies To Uplist Common Stock To Nasdaq